Your browser doesn't support javascript.
loading
Phage therapy: From biological mechanisms to future directions.
Strathdee, Steffanie A; Hatfull, Graham F; Mutalik, Vivek K; Schooley, Robert T.
Afiliación
  • Strathdee SA; Center for Innovative Phage Applications and Therapeutics, Division of Infectious Disease and Global Public Health, University of California, San Diego, La Jolla, CA 92093-0507, USA. Electronic address: sstrathdee@health.ucsd.edu.
  • Hatfull GF; Department of Biological Sciences, University of Pittsburgh, Pittsburgh, PA 15260, USA.
  • Mutalik VK; Environmental Genomics and Systems Biology Division, Lawrence Berkeley National Laboratory, Berkeley, CA 94720, USA.
  • Schooley RT; Center for Innovative Phage Applications and Therapeutics, Division of Infectious Disease and Global Public Health, University of California, San Diego, La Jolla, CA 92093-0507, USA.
Cell ; 186(1): 17-31, 2023 01 05.
Article en En | MEDLINE | ID: mdl-36608652
Increasing antimicrobial resistance rates have revitalized bacteriophage (phage) research, the natural predators of bacteria discovered over 100 years ago. In order to use phages therapeutically, they should (1) preferably be lytic, (2) kill the bacterial host efficiently, and (3) be fully characterized to exclude side effects. Developing therapeutic phages takes a coordinated effort of multiple stakeholders. Herein, we review the state of the art in phage therapy, covering biological mechanisms, clinical applications, remaining challenges, and future directions involving naturally occurring and genetically modified or synthetic phages.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Bacteriófagos / Terapia de Fagos Idioma: En Revista: Cell Año: 2023 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Bacteriófagos / Terapia de Fagos Idioma: En Revista: Cell Año: 2023 Tipo del documento: Article